Subscribe to Newsletter

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Content by Stephanie Vine:

 Business & Regulation Standards & Regulation

Saying Farewell to the Famous Horse Tweet

| Stephanie Vine | 5 min read

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use
Manufacture Advanced Medicine

Introducing a Regulatory Playbook for Gene Therapy

| Stephanie Vine

In this video interview, Courtney Silverthorn explains the inspiration behind a free regulatory playbook for gene therapy manufacturers.
Business & Regulation Standards & Regulation

FDA Warning Letters: April 2024 Edition

| Stephanie Vine | 6 min read

Production records written using erasable markers, use of expired raw materials, and more.
Business & Regulation Technology and Equipment

Interphex: The Finale

| Stephanie Vine | 2 min read

Day 3 closes out with sessions on drug delivery devices

Business & Regulation Technology and Equipment

Day 2 of Interphex

| Stephanie Vine | 2 min read

Looking for a guide to day 2 of the show? We’ve got you covered.

Discovery & Development Dosage Forms

Innovation Awards: The Grand Winner

| Stephanie Vine | 2 min read

Lonza’s Enprotect Capsule is the recipient of The Medicine Maker 2023 Innovation Awards.
Business & Regulation Technology and Equipment

Welcome to Interphex 2024!

| Stephanie Vine | 3 min read

Interphex kicks off today in New York. Here’s what to look out for on day 1.
Manufacture Advanced Medicine

Interviewing Luigi Naldini: Be a Little Different

| Stephanie Vine | 8 min read

How the drive to try something new led to the development of lentiviral vectors for gene therapy.
Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 2

| Stephanie Vine

Cardinal Health’s Fran Gregory looks at innovative payment models for cell and gene therapies.

Business & Regulation Business Practice

Video Interview: The High Costs of Advanced Therapies, Part 1

| Stephanie Vine

Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

April Issue of The Medicine Maker